Projects funded by the NCN
Selective modulation of PPARγ signaling as a new therapeutic strategy for Alzheimer's disease
2022/45/N/NZ7/01418
Keywords:
neuroprotection Alzheimer's Disease PPAR gamma apoptosis autophagy epigenetics miRNA lncRNA
Descriptors:
- NZ3_005:
- NZ7_012:
- NZ7_014:
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Instytut Farmakologii PAN
woj. małopolskie
Principal investigator (from the host institution):
Karolina Barbara Przepiórska-Drońska
Number of co-investigators in the project: 3
Call: PRELUDIUM 21 - announced on 2022-03-28
Amount awarded: 210 000 PLN
Project start date (Y-m-d): 2023-02-02
Project end date (Y-m-d): 2026-02-01
Project duration:: 36 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publications will be made available after the final report has been accepted.